We are live on ! Find out more
BFM

Boston Financial Management Portfolio holdings

AUM $3.31B
1-Year Est. Return 19.4%
This Fund
S&P 500
This Quarter Est. Return
+8.65%
1 Year Est. Return
+19.4%
3 Year Est. Return
+30.07%
5 Year Est. Return
+107.8%
10 Year Est. Return
+274.5%
AUM
$729M
AUM Growth
+$63.7M
Cap. Flow
+$10.4M
Cap. Flow %
1.42%
Top 10 Hldgs %
28.18%
Holding
206
New
12
Increased
105
Reduced
63
Closed
2

Top Buys

Rank Stock Value
1
AMT icon
American Tower
AMT
+$1.85M
2
OKE icon
Oneok
OKE
+$1.67M
3
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$1.46M
4
CTSH icon
Cognizant
CTSH
+$1.22M
5
ADBE icon
Adobe
ADBE
+$1.22M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$6.76M
2
IBM icon
IBM
IBM
+$3.53M
3
MYGN icon
Myriad Genetics
MYGN
+$1.31M
4
TGT icon
Target
TGT
+$1.13M
5
CTXS
Citrix Systems Inc
CTXS
+$1.08M

Sector Composition

Rank Sector Weight
1 Healthcare 22.98%
2 Industrials 11.55%
3 Energy 11.36%
4 Consumer Staples 10.91%
5 Technology 10.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLX icon
151
Clorox
CLX
$11.6B
$666K 0.09%
7,175
-875
-11% -$78.8K
CTXS
152
DELISTED
Citrix Systems Inc
CTXS
$643K 0.09%
12,771
-22,751
-64% -$1.08M
UN
153
DELISTED
Unilever NV New York Registry Shares
UN
$591K 0.08%
14,680
-145
-1% -$5.64K
DIS icon
154
Walt Disney
DIS
$167B
$588K 0.08%
7,696
+340
+5% +$23.6K
LOW icon
155
Lowe's Companies
LOW
$117B
$582K 0.08%
11,755
+560
+5% +$27.2K
TEVA icon
156
Teva Pharmaceuticals
TEVA
$40.8B
$565K 0.08%
14,106
-2,245
-14% -$88.4K
NEM icon
157
Newmont
NEM
$98.7B
$553K 0.08%
23,992
-18,217
-43% -$468K
DLTR icon
158
Dollar Tree
DLTR
$24.4B
$540K 0.07%
+9,565
New +$551K
BRK.A icon
159
Berkshire Hathaway Class A
BRK.A
$1.1T
$534K 0.07%
3
MO icon
160
Altria Group
MO
$114B
$532K 0.07%
13,868
MDY icon
161
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.6B
$494K 0.07%
2,024
COP icon
162
ConocoPhillips
COP
$147B
$437K 0.06%
6,190
-880
-12% -$63.2K
CMCSK
163
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
$429K 0.06%
8,591
-25
-0.3% -$1.25K
HON icon
164
Honeywell
HON
$77B
$424K 0.06%
5,163
EPB
165
DELISTED
EL PASO PIPELINE PARTNERS, L.P. COM UNITS REPSTG LTD PART
EPB
$420K 0.06%
11,675
GIS icon
166
General Mills
GIS
$19.1B
$418K 0.06%
8,373
-100
-1% -$4.98K
QGENF
167
DELISTED
QIAGEN NV
QGENF
$410K 0.06%
17,225
NBL
168
DELISTED
Noble Energy, Inc.
NBL
$409K 0.06%
6,000
VEA icon
169
Vanguard FTSE Developed Markets ETF
VEA
$229B
$407K 0.06%
+9,775
New +$396K
USB icon
170
US Bancorp
USB
$98.2B
$394K 0.05%
9,743
-600
-6% -$23K
CP icon
171
Canadian Pacific Kansas City
CP
$78.1B
$393K 0.05%
13,000
WU icon
172
Western Union
WU
$1.98B
$392K 0.05%
22,720
-4,753
-17% -$83.3K
FISV
173
Fiserv Inc
FISV
$28.8B
$358K 0.05%
12,140
HSP
174
DELISTED
HOSPIRA INC
HSP
$358K 0.05%
8,675
SLV icon
175
iShares Silver Trust
SLV
$28B
$342K 0.05%
18,300
+500
+3% +$10K

Similar funds

Boston Financial Management's Q4 2013 Portfolio in Review

As of Q4 2013, Boston Financial Management held 206 positions worth $729M, up 9.6% from $666M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Boston Financial Management's Q4 2013 filing shows 12 new, 105 increased, 63 reduced and 2 closed positions. Its largest new stake was American Tower: 23,815 shares worth $1.9M. The largest sale was Pfizer, an estimated $6.76M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 24% a quarter earlier, followed by Industrials and Energy.

  • Boston Financial Management's largest Q4 2013 buy was American Tower: 23,815 shares worth $1.9M.
  • Boston Financial Management added most to Oneok in Q4 2013, an estimated $1.67M increase.
  • Boston Financial Management's biggest Q4 2013 reduction was Pfizer, cutting an estimated $6.76M.
  • Boston Financial Management fully exited Myriad Genetics in Q4 2013, selling an estimated $1.31M.
  • Boston Financial Management's ten largest holdings make up 28% of its $729M portfolio in Q4 2013.
  • Boston Financial Management opened 12 new positions and closed 2 in Q4 2013.
  • Boston Financial Management's portfolio value rose 9.6% quarter-over-quarter to $729M.

Based on Boston Financial Management's 13F filing for Q4 2013, filed 25 Feb 2014.